Semaglutide and tirzepatide confer greater improvements in life expectancy than naltrexone/bupropion and ...

Compounded GLP-1s have given rise to a cottage industry offering cheaper weight loss medications to many Americans — but now ...

Tirzepatide — a drug that acts both as a GLP-1 agonist and a GIP agonist — is the active ingredient in an even more powerful ...

To be a person in the year 2025 is to encounter, in one way or another, the marketing onslaught for compounded ...

Now that the shortage of semaglutide injection products has been resolved, the Food and Drug Administration (FDA) will restrict third parties ...

After years of weight loss drug shortages, the FDA is saying there’s now an adequate supply for most medications and they ...

Neoadjuvant semaglutide before metabolic and bariatric surgery (MBS) is not beneficial in terms of weight loss, according to ...

But the newest study that has gone viral is an even more impressive outcome. Headlines are claiming that researchers have ...

This economic evaluation found that although tirzepatide and semaglutide offered substantial long-term health benefits, they were not ...

Zepbound contains the same active ingredient, tirzepatide, as Mounjaro, which is also made by Lilly and is FDA-approved to treat Type 2 diabetes. Some doctors also prescribe Mounjaro "off-label" for ...

Compounding pharmacies will have to stop producing copycats of tirzepatide, the active ingredient in the blockbuster weight loss drugs Mounjaro and Zepbound, in a matter of days. That’s because a ...

Novo Nordisk’s weight loss drug Wegovy is linked to an increased risk of hair loss, a study suggests. Meanwhile, Dexcom ...